{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:21:39Z","timestamp":1740122499991,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s10552-022-01635-1","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T09:11:42Z","timestamp":1664529102000},"page":"1445-1451","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Body mass index and additional risk factors for cancer in adults with cystic fibrosis"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3133-1772","authenticated-orcid":false,"given":"Rita M.","family":"Knotts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhezhen","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John B.","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Keating","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"DiMango","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian A.","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,30]]},"reference":[{"key":"1635_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","volume":"8","author":"SC Bell","year":"2020","unstructured":"Bell SC, Mall MA, Gutierrez H, Macek M, Madge S, Davies JC et al (2020) The future of cystic fibrosis care: a global perspective. Lancet Respir Med 8:65\u2013124","journal-title":"Lancet Respir Med"},{"issue":"105","key":"1635_CR2","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/jnci\/djs481","volume":"16","author":"P Maisonneuve","year":"2013","unstructured":"Maisonneuve P, Marshall BC, Knapp EA, Lowenfels AB (2013) Cancer risk in cystic fibrosis: a 20-year nationwide study from the United States. J Natl Cancer Inst 16(105):122\u2013129","journal-title":"J Natl Cancer Inst"},{"issue":"373","key":"1635_CR3","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1016\/S0140-6736(09)60327-5","volume":"30","author":"BP O\u2019Sullivan","year":"2009","unstructured":"O\u2019Sullivan BP, Freedman SD (2009) Cystic fibrosis. Lancet 30(373):1891\u20131904","journal-title":"Lancet"},{"key":"1635_CR4","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1111\/ajt.13549","volume":"16","author":"M Safaeian","year":"2016","unstructured":"Safaeian M, Robbins HA, Berndt SI, Lynch CF, Fraumeni JF, Engels EA (2016) Risk of colorectal cancer after solid organ transplantation in the United States. Am J Transpl 16:960\u2013967","journal-title":"Am J Transpl"},{"issue":"143","key":"1635_CR5","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1002\/ijc.31553","volume":"1","author":"X Fang","year":"2018","unstructured":"Fang X, Wei J, He X, Lian J, Han D, An P et al (2018) Quantitative association between body mass index and the risk of cancer: a global meta-analysis of prospective cohort studies. Int J Cancer 1(143):1595\u20131603","journal-title":"Int J Cancer"},{"key":"1635_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.metabol.2018.11.001","volume":"92","author":"KI Avgerinos","year":"2019","unstructured":"Avgerinos KI, Spyrou N, Mantzoros CS, Dalamaga M (2019) Obesity and cancer risk: emerging biological mechanisms and perspectives. Metab Clin Exp 92:121\u2013135","journal-title":"Metab Clin Exp"},{"key":"1635_CR7","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1378\/chest.11-2124","volume":"142","author":"AW Fogarty","year":"2012","unstructured":"Fogarty AW, Britton J, Clayton A, Smyth AR (2012) Are measures of body habitus associated with mortality in cystic fibrosis? Chest 142:712\u2013717","journal-title":"Chest"},{"key":"1635_CR8","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/ppul.20619","volume":"42","author":"JM Courtney","year":"2007","unstructured":"Courtney JM, Bradley J, Mccaughan J, O\u2019Connor TM, Shortt C, Bredin CP et al (2007) Predictors of mortality in adults with cystic fibrosis. Pediatr Pulmonol 42:525\u2013532","journal-title":"Pediatr Pulmonol"},{"issue":"Suppl 1","key":"1635_CR9","doi-asserted-by":"publisher","first-page":"i15","DOI":"10.1136\/bmjqs-2013-002369","volume":"23","author":"MP Boyle","year":"2014","unstructured":"Boyle MP, Sabadosa KA, Quinton HB, Marshall BC, Schechter MS (2014) Key findings of the US Cystic Fibrosis Foundation\u2019s clinical practice benchmarking project. BMJ Qual Saf 23(Suppl 1):i15\u2013i22","journal-title":"BMJ Qual Saf"},{"key":"1635_CR10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jcf.2015.03.003","volume":"14","author":"AM Cantin","year":"2015","unstructured":"Cantin AM, Hartl D, Konstan MW, Chmiel JF (2015) Inflammation in cystic fibrosis lung disease: pathogenesis and therapy. J Cyst Fibros 14:419\u2013430","journal-title":"J Cyst Fibros"},{"key":"1635_CR11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1183\/09031936.00166412","volume":"43","author":"E Kerem","year":"2014","unstructured":"Kerem E, Viviani L, Zolin A, MacNeill S, Hatziagorou E, Ellemunter H et al (2014) Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry. Eur Respir J 43:125\u2013133","journal-title":"Eur Respir J"},{"key":"1635_CR12","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1136\/thorax.56.10.746","volume":"56","author":"R Sharma","year":"2001","unstructured":"Sharma R, Florea VG, Bolger AP, Doehner W, Florea ND, Coats AJ et al (2001) Wasting as an independent predictor of mortality in patients with cystic fibrosis. Thorax 56:746\u2013750","journal-title":"Thorax"},{"key":"1635_CR13","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1513\/AnnalsATS.201511-781OC","volume":"13","author":"EA Knapp","year":"2016","unstructured":"Knapp EA, Fink AK, Goss CH, Sewall A, Ostrenga J, Dowd C et al (2016) The cystic fibrosis foundation patient registry, design and methods of a national observational disease registry. Ann Am Thorac Soc 13:1173\u20131179","journal-title":"Ann Am Thorac Soc"},{"issue":"95","key":"1635_CR14","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/jnci\/95.5.381","volume":"5","author":"P Maisonneuve","year":"2003","unstructured":"Maisonneuve P, FitzSimmons SC, Neglia JP, Campbell PW, Lowenfels AB (2003) Cancer risk in nontransplanted and transplanted cystic fibrosis patients: a 10-year study. J Natl Cancer Inst 5(95):381\u2013387","journal-title":"J Natl Cancer Inst"},{"key":"1635_CR15","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S1470-2045(18)30188-8","volume":"19","author":"A Yamada","year":"2018","unstructured":"Yamada A, Komaki Y, Komaki F, Micic D, Zullow S, Sakuraba A (2018) Risk of gastrointestinal cancers in patients with cystic fibrosis: a systematic review and meta-analysis. Lancet Oncol 19:758\u2013767","journal-title":"Lancet Oncol"},{"key":"1635_CR16","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJM199502233320803","volume":"332","author":"JP Neglia","year":"1995","unstructured":"Neglia JP, FitzSimmons SC, Maisonneuve P, Sch\u00f6ni MH, Sch\u00f6ni-Affolter F, Corey M et al (1995) The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group. N Engl J Med 332:494\u2013499","journal-title":"N Engl J Med"},{"issue":"7","key":"1635_CR17","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.7150\/jca.16884","volume":"26","author":"R Divella","year":"2016","unstructured":"Divella R, De Luca R, Abbate I, Naglieri E, Daniele A (2016) Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation. J Cancer 26(7):2346\u20132359","journal-title":"J Cancer"},{"key":"1635_CR18","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/MPG.0b013e3181d1b013","volume":"51","author":"SL Werlin","year":"2010","unstructured":"Werlin SL, Benuri-Silbiger I, Kerem E, Adler SN, Goldin E, Zimmerman J et al (2010) Evidence of intestinal inflammation in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 51:304\u2013308","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1635_CR19","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3109\/00365513.2010.486869","volume":"70","author":"A Lisowska","year":"2010","unstructured":"Lisowska A, Madry E, Pogorzelski A, Szyd\u0142owski J, Radzikowski A, Walkowiak J (2010) Small intestine bacterial overgrowth does not correspond to intestinal inflammation in cystic fibrosis. Scand J Clin Lab Invest 70:322\u2013326","journal-title":"Scand J Clin Lab Invest"},{"key":"1635_CR20","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1136\/adc.82.5.394","volume":"82","author":"RL Smyth","year":"2000","unstructured":"Smyth RL, Croft NM, O\u2019Hea U, Marshall TG, Ferguson A (2000) Intestinal inflammation in cystic fibrosis. Arch Dis Child 82:394\u2013399","journal-title":"Arch Dis Child"},{"issue":"20","key":"1635_CR21","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/j.1365-2036.2004.02174.x","volume":"1","author":"E Bruzzese","year":"2004","unstructured":"Bruzzese E, Raia V, Gaudiello G, Polito G, Buccigrossi V, Formicola V et al (2004) Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Aliment Pharmacol Ther 1(20):813\u2013819","journal-title":"Aliment Pharmacol Ther"},{"key":"1635_CR22","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jcf.2013.08.009","volume":"13","author":"FM Hollander","year":"2014","unstructured":"Hollander FM, van Pierre DD, de Roos NM, van de Graaf EA, Iestra JA (2014) Effects of nutritional status and dietetic interventions on survival in cystic fibrosis patients before and after lung transplantation. J Cyst Fibros 13:212\u2013218","journal-title":"J Cyst Fibros"},{"key":"1635_CR23","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.jpeds.2012.08.040","volume":"162","author":"EH Yen","year":"2013","unstructured":"Yen EH, Quinton H, Borowitz D (2013) Better nutritional status in early childhood is associated with improved clinical outcomes and survival in patients with cystic fibrosis. J Pediatr 162:530-535.e1","journal-title":"J Pediatr"},{"issue":"153","key":"1635_CR24","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/aje\/153.4.345","volume":"15","author":"TG Liou","year":"2001","unstructured":"Liou TG, Adler FR, Fitzsimmons SC, Cahill BC, Hibbs JR, Marshall BC (2001) Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol 15(153):345\u2013352","journal-title":"Am J Epidemiol"},{"key":"1635_CR25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jcf.2012.10.003","volume":"12","author":"G Duytschaever","year":"2013","unstructured":"Duytschaever G, Huys G, Bekaert M, Boulanger L, De Boeck K, Vandamme P (2013) Dysbiosis of bifidobacteria and Clostridium cluster XIVa in the cystic fibrosis fecal microbiota. J Cyst Fibros 12:206\u2013215","journal-title":"J Cyst Fibros"},{"issue":"8","key":"1635_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061176","volume":"17","author":"S Schippa","year":"2013","unstructured":"Schippa S, Iebba V, Santangelo F, Gagliardi A, De Biase RV, Stamato A et al (2013) Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients. PLoS ONE 17(8):e61176","journal-title":"PLoS ONE"},{"issue":"6","key":"1635_CR27","doi-asserted-by":"publisher","first-page":"22493","DOI":"10.1038\/srep22493","volume":"4","author":"O Manor","year":"2016","unstructured":"Manor O, Levy R, Pope CE, Hayden HS, Brittnacher MJ, Carr R et al (2016) Metagenomic evidence for taxonomic dysbiosis and functional imbalance in the gastrointestinal tracts of children with cystic fibrosis. Sci Rep 4(6):22493","journal-title":"Sci Rep"},{"issue":"17","key":"1635_CR28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12866-017-0968-8","volume":"9","author":"DG Burke","year":"2017","unstructured":"Burke DG, Fouhy F, Harrison MJ, Rea MC, Cotter PD, O\u2019Sullivan O et al (2017) The altered gut microbiota in adults with cystic fibrosis. BMC Microbiol 9(17):58","journal-title":"BMC Microbiol"},{"issue":"5","key":"1635_CR29","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.0740","volume":"1","author":"R Nagy","year":"2022","unstructured":"Nagy R, Gede N, Ocskay K, Dobai B-M, Abada A, Vereczkei Z et al (2022) Association of body mass index with clinical outcomes in patients with cystic fibrosis: a systematic review and meta-analysis. JAMA Netw Open 1(5):e220740","journal-title":"JAMA Netw Open"},{"key":"1635_CR30","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jcf.2019.10.004","volume":"19","author":"T Harindhanavudhi","year":"2020","unstructured":"Harindhanavudhi T, Wang Q, Dunitz J, Moran A, Moheet A (2020) Prevalence and factors associated with overweight and obesity in adults with cystic fibrosis: a single-center analysis. J Cyst Fibros 19:139\u2013145","journal-title":"J Cyst Fibros"},{"key":"1635_CR31","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1183\/09031936.00115312","volume":"42","author":"A Singanayagam","year":"2013","unstructured":"Singanayagam A, Singanayagam A, Chalmers JD (2013) Obesity is associated with improved survival in community-acquired pneumonia. Eur Respir J 42:180\u2013187","journal-title":"Eur Respir J"},{"key":"1635_CR32","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s10654-019-00587-2","volume":"34","author":"S-M Jeong","year":"2019","unstructured":"Jeong S-M, Lee DH, Giovannucci EL (2019) Predicted lean body mass, fat mass and risk of lung cancer: prospective US cohort study. Eur J Epidemiol 34:1151\u20131160","journal-title":"Eur J Epidemiol"},{"key":"1635_CR33","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1136\/gutjnl-2020-322753","volume":"70","author":"F Frost","year":"2021","unstructured":"Frost F, Kacprowski T, R\u00fchlemann M, Pietzner M, Bang C, Franke A et al (2021) Long-term instability of the intestinal microbiome is associated with metabolic liver disease, low microbiota diversity, diabetes mellitus and impaired exocrine pancreatic function. Gut 70:522\u2013530","journal-title":"Gut"},{"key":"1635_CR34","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000232","volume":"11","author":"F Frost","year":"2020","unstructured":"Frost F, Weiss FU, Sendler M, Kacprowski T, R\u00fchlemann M, Bang C et al (2020) The gut microbiome in patients with chronic pancreatitis is characterized by significant dysbiosis and overgrowth by opportunistic pathogens. Clin Transl Gastroenterol 11:e00232","journal-title":"Clin Transl Gastroenterol"},{"issue":"Suppl 2","key":"1635_CR35","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1016\/j.jcf.2017.06.011","volume":"16","author":"VK Singh","year":"2017","unstructured":"Singh VK, Schwarzenberg SJ (2017) Pancreatic insufficiency in cystic fibrosis. J Cyst Fibros 16(Suppl 2):S70\u2013S78","journal-title":"J Cyst Fibros"},{"key":"1635_CR36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1053\/j.seminoncol.2014.12.002","volume":"42","author":"TP Yeo","year":"2015","unstructured":"Yeo TP (2015) Demographics, epidemiology, and inheritance of pancreatic ductal adenocarcinoma. Semin Oncol 42:8\u201318","journal-title":"Semin Oncol"},{"issue":"116","key":"1635_CR37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/cncr.24697","volume":"1","author":"RR McWilliams","year":"2010","unstructured":"McWilliams RR, Petersen GM, Rabe KG, Holtegaard LM, Lynch PJ, Bishop MD et al (2010) Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and risk for pancreatic adenocarcinoma. Cancer 1(116):203\u2013209","journal-title":"Cancer"},{"issue":"Suppl 2","key":"1635_CR38","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1016\/j.jcf.2017.07.004","volume":"16","author":"AJ Freeman","year":"2017","unstructured":"Freeman AJ, Ooi CY (2017) Pancreatitis and pancreatic cystosis in cystic fibrosis. J Cyst Fibros 16(Suppl 2):S79\u2013S86","journal-title":"J Cyst Fibros"},{"key":"1635_CR39","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1136\/gut.2007.125278","volume":"56","author":"P Maisonneuve","year":"2007","unstructured":"Maisonneuve P, Marshall BC, Lowenfels AB (2007) Risk of pancreatic cancer in patients with cystic fibrosis. Gut 56:1327\u20131328","journal-title":"Gut"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-022-01635-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10552-022-01635-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-022-01635-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T05:55:18Z","timestamp":1701150918000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10552-022-01635-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1635"],"URL":"https:\/\/doi.org\/10.1007\/s10552-022-01635-1","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"type":"print","value":"0957-5243"},{"type":"electronic","value":"1573-7225"}],"subject":[],"published":{"date-parts":[[2022,9,30]]},"assertion":[{"value":"18 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}